Phosphatidylinositol 3-kinase mediates heregulin-induced growth inhibition in human epithelial cells

被引:0
作者
Hamburger, AW
Yoo, JY
机构
[1] UNIV MARYLAND,DEPT PATHOL,BALTIMORE,MD 21201
[2] UNIV MARYLAND,PROGRAM MOL & CELL BIOL,BALTIMORE,MD 21201
关键词
breast cancer; erbB receptors; heregulin; phosphatidylinositol; 3-kinase;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activation of phosphatidylinositol 3-kinase (PI-3K) has been shown to be critical for heregulin induced mitogenesis of human breast epithelial cells. However, the inhibitory effects of HRG have not been linked to PI3K activation The purpose of these experiments was to determine the effects of heregulin beta 1 (HRG) on growth and PI3K activation of a nonneoplastic human mammary epithelial cell line, 184B5. The results of these experiments indicated that low concentrations of HRG increased the growth of 184B5 cells three fold, while high concentrations inhibited growth by 50%. HRG at all concentrations tested increased tyrosine phosphorylation of erbB3. Similarly, HRG at all concentrations stimulated the association of PI3K with erbB3. Wortmannin, an inhibitor of PI3K enzymatic activity, reversed both the inhibitory and stimulatory effects of HRG on incorporation of [H-3] thymidine into DNA. We conclude that both the growth inhibitory and stimulatory effects of HRG in nonneoplastic human mammary epithelial cells are mediated by activation of PI3K.
引用
收藏
页码:2197 / 2200
页数:4
相关论文
共 50 条
  • [21] Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase
    Nakanishi, K
    Fujimoto, J
    Ueki, T
    Kishimoto, K
    Hashimoto-Tamaoki, T
    Furuyama, J
    Itoh, T
    Sasaki, Y
    Okamoto, E
    CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (06) : 507 - 514
  • [22] Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells
    Yamakawa, T
    Tanaka, S
    Kamei, J
    Kadonosono, K
    Okuda, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 478 (01) : 39 - 46
  • [23] Inhibition of neuroblastoma cell phosphatidylinositol 3-kinase by CDP-diacylglycerol and phosphatidate
    Lavie, Y
    Agranoff, BW
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (02) : 811 - 816
  • [24] Isoform-Selective Phosphatidylinositol 3-Kinase Inhibition in Cancer
    Bergholz, Johann S.
    Roberts, Thomas M.
    Zhao, Jean J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (13) : 1339 - +
  • [25] Involvement of phosphatidylinositol 3-kinase in cAMP- and cGMP-induced duodenal epithelial CFTR activation in mice
    Tuo, Biguang
    Wen, Guorong
    Zhang, Yalin
    Liu, Xuemei
    Wang, Xue
    Liu, Xiaoqiang
    Dong, Hui
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2009, 297 (03): : C503 - C515
  • [26] Increased phosphorylation of AKAP by inhibition of phosphatidylinositol 3-kinase enhances human sperm motility through tall recruitment of protein kinase A
    Luconi, M
    Carloni, V
    Marra, F
    Ferruzzi, P
    Forti, G
    Baldi, E
    JOURNAL OF CELL SCIENCE, 2004, 117 (07) : 1235 - 1246
  • [27] Dysregulation of phosphatidylinositol 3-kinase and downstream effectors in human breast cancer
    Salh, B
    Marotta, A
    Wagey, R
    Sayed, M
    Pelech, S
    INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (01) : 148 - 154
  • [28] Hepatocyte Growth Factor Inhibits Anoikis of Pancreatic Carcinoma Cells Through Phosphatidylinositol 3-Kinase Pathway
    Watanabe, Satoshi
    Kishimoto, Takashi
    Yokosuka, Osamu
    PANCREAS, 2011, 40 (04) : 608 - 614
  • [29] Cilnidipine mediates a neuroprotective effect by scavenging free radicals and activating the phosphatidylinositol 3-kinase pathway
    Lee, Young Joo
    Park, Kee Hyung
    Park, Hyun-Hee
    Kim, Yun Jin
    Lee, Kyu-Yong
    Kim, Seung Hyun
    Koh, Seong-Ho
    JOURNAL OF NEUROCHEMISTRY, 2009, 111 (01) : 90 - 100
  • [30] H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3
    Chakrabarty, A.
    Rexer, B. N.
    Wang, S. E.
    Cook, R. S.
    Engelman, J. A.
    Arteaga, C. L.
    ONCOGENE, 2010, 29 (37) : 5193 - 5203